• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Up 0.17%

    AbbVie Inc. (ABBV)

    -NYSE
    62.09 Up 0.15(0.24%) Feb 24, 4:02PM EST
    |After Hours : 62.25 Up 0.16 (0.26%) Feb 24, 7:51PM EST
    Prev Close:61.94
    Open:61.92
    Bid:N/A
    Ask:N/A
    1y Target Est:69.78
    Beta:1.4687
    Earnings Date:Apr 26 - May 1 (Est.)
    Day's Range:61.49 - 62.23
    52wk Range:54.24 - 68.12
    Volume:6,536,399
    Avg Vol (3m):7,269,790
    Market Cap:100.90B
    P/E (ttm):17.10
    EPS (ttm):3.63
    Div & Yield:2.56 (4.13%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ABBVUp 0.24%100.90B
    1 0.00%N/A
    PFEUp 0.59%207.90B
    MRKUp 0.47%182.41B

    Key Statistics

    Forward P/E (1 yr):9.64
    P/S (ttm):3.85
    Ex-Dividend Date:11-Jan-17

    Analysts

    Annual EPS Est (Dec-17) :5.49
    Quarterly EPS Est (Mar-17) :1.26
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):0.79

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA, an oral therapy for the tre... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback